Skip to main content
Erschienen in: Acta Neurochirurgica 8/2010

01.08.2010 | Clinical Article

Functional impairments caused by chiasma syndromes prior to and following transsphenoidal pituitary adenoma surgery

verfasst von: Rudolf A. Kristof, Daniel Kirchhofer, Daniel Handzel, Georg Neuloh, Johannes Schramm, Christian-Andreas Mueller, Nicole Eter

Erschienen in: Acta Neurochirurgica | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To describe the functional impairment caused by chiasma syndromes (CS) prior to and following transsphenoidal pituitary adenoma surgery.

Methods

Pertinent data of a successive series of patients operated transsphenoidally for the first time for pituitary adenoma were retrospectively analyzed. The degree of functional impairment caused by the impairment of vision was quantified according to the resulting degree of disability (DOD). A DOD of ≥30 is considered substantial.

Results

None of the 197 of 304 (64.9%) patients without preoperative chiasma syndrome (CS) experienced postoperative worsening of their visual acuity or their visual fields. Thus, no change of their vision-related DOD (V-DOD) did occur. One hundred and seven (35.1%) of the patients presented preoperatively with CS. Postoperatively, 42.9% of the CS remitted completely, 38.3% improved, 11.2% remained unchanged, and 7.4% worsened. Accordingly, the median V-DOD improved significantly from 30 (0; 100) to 0 (0; 100). The prevalence of patients with V-DOD ≥30 dropped significantly from 51.4% preoperatively to 16.4% postoperatively. Postoperatively, the median V-DOD improved significantly up to 3 months postoperatively. Thereafter, no further significant changes occurred. However, in patients with preoperative CS, the median V-DOD as well as the prevalence of patients with a V-DOD ≥30 remained postoperatively significantly higher compared to patients without preoperative CS.

Conclusions

Visual impairments due to CS frequently caused substantial DOD preoperatively. Postoperatively, the median degree of V-DOD as well as the prevalence of substantial V-DOD improved significantly. However, in patients with preoperative CS, V-DOD remained postoperatively significantly higher than V-DOD of patients without preoperative CS.
Literatur
1.
Zurück zum Zitat Blaauw G, Braakman R, Cuhadar M, Hoeve LJ, Lamberts SW, Poublon RM, Singh R, Wijngaarde R (1986) Influence of transsphenoidal hypophysectomy on visual deficit due to a pituitary tumour. Acta Neurochir (Wien) 83:79–82CrossRef Blaauw G, Braakman R, Cuhadar M, Hoeve LJ, Lamberts SW, Poublon RM, Singh R, Wijngaarde R (1986) Influence of transsphenoidal hypophysectomy on visual deficit due to a pituitary tumour. Acta Neurochir (Wien) 83:79–82CrossRef
2.
Zurück zum Zitat Black PM, Zervas NT, Candia G (1988) Management of large pituitary adenomas by transsphenoidal surgery. Surg Neurol 29:443–447PubMedCrossRef Black PM, Zervas NT, Candia G (1988) Management of large pituitary adenomas by transsphenoidal surgery. Surg Neurol 29:443–447PubMedCrossRef
3.
Zurück zum Zitat Chacko AG, Babu KS, Chandy MJ (1996) Value of visual evoked potential monitoring during trans-sphenoidal pituitary surgery. Br J Neurosurg 10:275–278PubMedCrossRef Chacko AG, Babu KS, Chandy MJ (1996) Value of visual evoked potential monitoring during trans-sphenoidal pituitary surgery. Br J Neurosurg 10:275–278PubMedCrossRef
4.
Zurück zum Zitat Cinalli G, Cappabianca P, de Falco R, Spennato P, Cianciulli E, Cavallo LM, Esposito F, Ruggiero C, Maggi G, de Divitiis E (2005) Current state and future development of intracranial neuroendoscopic surgery. Expert Rev Med Devices 2:351–373PubMedCrossRef Cinalli G, Cappabianca P, de Falco R, Spennato P, Cianciulli E, Cavallo LM, Esposito F, Ruggiero C, Maggi G, de Divitiis E (2005) Current state and future development of intracranial neuroendoscopic surgery. Expert Rev Med Devices 2:351–373PubMedCrossRef
5.
Zurück zum Zitat Cohen AR, Cooper PR, Kupersmith MJ, Flamm ES, Ransohoff J (1985) Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurgery 17:446–452PubMedCrossRef Cohen AR, Cooper PR, Kupersmith MJ, Flamm ES, Ransohoff J (1985) Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurgery 17:446–452PubMedCrossRef
6.
Zurück zum Zitat Dekkers OM, Pereira AM, Romijn JA (2008) Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 93:3717–3726PubMedCrossRef Dekkers OM, Pereira AM, Romijn JA (2008) Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 93:3717–3726PubMedCrossRef
7.
Zurück zum Zitat Ferrante L, Trillo G, Ramundo E, Celli P, Jaffrain-Rea ML, Salvati M, Esposito V, Roperto R, Osti MF, Minniti G (2002) Surgical treatment of pituitary tumors in the elderly: clinical outcome and long-term follow-up. J Neurooncol 60:185–191PubMedCrossRef Ferrante L, Trillo G, Ramundo E, Celli P, Jaffrain-Rea ML, Salvati M, Esposito V, Roperto R, Osti MF, Minniti G (2002) Surgical treatment of pituitary tumors in the elderly: clinical outcome and long-term follow-up. J Neurooncol 60:185–191PubMedCrossRef
8.
Zurück zum Zitat Findlay G, McFadzean RM, Teasdale G (1983) Recovery of vision following treatment of pituitary tumours; application of a new system of assessment to patients treated by transsphenoidal operation. Acta Neurochir (Wien) 68:175–186CrossRef Findlay G, McFadzean RM, Teasdale G (1983) Recovery of vision following treatment of pituitary tumours; application of a new system of assessment to patients treated by transsphenoidal operation. Acta Neurochir (Wien) 68:175–186CrossRef
9.
Zurück zum Zitat Gnanalingham KK, Bhattacharjee S, Pennington R, Ng J, Mendoza N (2005) The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome. J Neurol Neurosurg Psychiatry 76:415–419PubMedCrossRef Gnanalingham KK, Bhattacharjee S, Pennington R, Ng J, Mendoza N (2005) The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome. J Neurol Neurosurg Psychiatry 76:415–419PubMedCrossRef
10.
Zurück zum Zitat Gnjidic Z, Ivekovic R, Rumboldt Z, Malenica M, Vizner B, Berkovic M (2002) Chiasma syndrome in acromegalic patients—correlation of neuroradiologic and neuroophthalmologic findings. Coll Antropol 26:601–608PubMed Gnjidic Z, Ivekovic R, Rumboldt Z, Malenica M, Vizner B, Berkovic M (2002) Chiasma syndrome in acromegalic patients—correlation of neuroradiologic and neuroophthalmologic findings. Coll Antropol 26:601–608PubMed
11.
Zurück zum Zitat Gramberg-Danielsen B (2005) Rechtliche Grundlagen der augenärztlichen Tätigkeit. Thieme, Stuttgart Gramberg-Danielsen B (2005) Rechtliche Grundlagen der augenärztlichen Tätigkeit. Thieme, Stuttgart
12.
Zurück zum Zitat Harris PE, Afshar F, Coates P, Doniach I, Wass JA, Besser GM, Grossman A (1989) The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours. Q J Med 71:417–427PubMed Harris PE, Afshar F, Coates P, Doniach I, Wass JA, Besser GM, Grossman A (1989) The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours. Q J Med 71:417–427PubMed
13.
Zurück zum Zitat Kaur A, Banerji D, Kumar D, Sharma K (1995) Visual status in suprasellar pituitary tumours. Indian J Ophthalmol 43:131–134PubMed Kaur A, Banerji D, Kumar D, Sharma K (1995) Visual status in suprasellar pituitary tumours. Indian J Ophthalmol 43:131–134PubMed
14.
Zurück zum Zitat Kerrison JB, Lynn MJ, Baer CA, Newman SA, Biousse V, Newman NJ (2000) Stages of improvement in visual fields after pituitary tumor resection. Am J Ophthalmol 130:813–820PubMedCrossRef Kerrison JB, Lynn MJ, Baer CA, Newman SA, Biousse V, Newman NJ (2000) Stages of improvement in visual fields after pituitary tumor resection. Am J Ophthalmol 130:813–820PubMedCrossRef
15.
Zurück zum Zitat Kristof RA, Schramm J, Redel L, Neuloh G, Wichers M, Klingmuller D (2002) Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas. Acta Neurochir (Wien) 144:555–561; discussion 561 Kristof RA, Schramm J, Redel L, Neuloh G, Wichers M, Klingmuller D (2002) Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas. Acta Neurochir (Wien) 144:555–561; discussion 561
16.
Zurück zum Zitat Laws ER Jr, Trautmann JC, Hollenhorst RW Jr (1977) Transsphenoidal decompression of the optic nerve and chiasm. Visual results in 62 patients. J Neurosurg 46:717–722PubMedCrossRef Laws ER Jr, Trautmann JC, Hollenhorst RW Jr (1977) Transsphenoidal decompression of the optic nerve and chiasm. Visual results in 62 patients. J Neurosurg 46:717–722PubMedCrossRef
17.
Zurück zum Zitat Lennerstrand G (1983) Visual recovery after treatment for pituitary adenoma. Acta Ophthalmol (Copenh) 61:1104–1117CrossRef Lennerstrand G (1983) Visual recovery after treatment for pituitary adenoma. Acta Ophthalmol (Copenh) 61:1104–1117CrossRef
18.
Zurück zum Zitat Lundstrom M, Frisen L (1977) Atrophy of optic nerve fibres in compression of the chiasm. Prognostic implications. Acta Ophthalmol (Copenh) 55:208–216CrossRef Lundstrom M, Frisen L (1977) Atrophy of optic nerve fibres in compression of the chiasm. Prognostic implications. Acta Ophthalmol (Copenh) 55:208–216CrossRef
19.
Zurück zum Zitat Marcus M, Vitale S, Calvert PC, Miller NR (1991) Visual parameters in patients with pituitary adenoma before and after transsphenoidal surgery. Aust N Z J Ophthalmol 19:111–118PubMedCrossRef Marcus M, Vitale S, Calvert PC, Miller NR (1991) Visual parameters in patients with pituitary adenoma before and after transsphenoidal surgery. Aust N Z J Ophthalmol 19:111–118PubMedCrossRef
20.
Zurück zum Zitat Peter M, De Tribolet N (1995) Visual outcome after transsphenoidal surgery for pituitary adenomas. Br J Neurosurg 9:151–157PubMedCrossRef Peter M, De Tribolet N (1995) Visual outcome after transsphenoidal surgery for pituitary adenomas. Br J Neurosurg 9:151–157PubMedCrossRef
21.
Zurück zum Zitat Powell M (1995) Recovery of vision following transsphenoidal surgery for pituitary adenomas. Br J Neurosurg 9:367–373PubMedCrossRef Powell M (1995) Recovery of vision following transsphenoidal surgery for pituitary adenomas. Br J Neurosurg 9:367–373PubMedCrossRef
22.
Zurück zum Zitat Sanno N, Teramoto A, Osamura RY, Horvath E, Kovacs K, Lloyd RV, Scheithauer BW (2003) Pathology of pituitary tumors. Neurosurg Clin N Am 14:25–39PubMedCrossRef Sanno N, Teramoto A, Osamura RY, Horvath E, Kovacs K, Lloyd RV, Scheithauer BW (2003) Pathology of pituitary tumors. Neurosurg Clin N Am 14:25–39PubMedCrossRef
23.
Zurück zum Zitat Schramm J, Kristof RA (2003) Selläre und periselläre Tumoren. In: Schlegel U, Weller M, Westphal M (eds) Neuroonkologie. Thieme, Stuttgart, pp 254–268 Schramm J, Kristof RA (2003) Selläre und periselläre Tumoren. In: Schlegel U, Weller M, Westphal M (eds) Neuroonkologie. Thieme, Stuttgart, pp 254–268
24.
Zurück zum Zitat Sullivan LJ, O'Day J, McNeill P (1991) Visual outcomes of pituitary adenoma surgery. St. Vincent's Hospital 1968–1987. J Clin Neuroophthalmol 11:262–267PubMed Sullivan LJ, O'Day J, McNeill P (1991) Visual outcomes of pituitary adenoma surgery. St. Vincent's Hospital 1968–1987. J Clin Neuroophthalmol 11:262–267PubMed
25.
Zurück zum Zitat Symon L, Jakubowski J (1979) Transcranial management of pituitary tumours with suprasellar extension. J Neurol Neurosurg Psychiatry 42:123–133PubMedCrossRef Symon L, Jakubowski J (1979) Transcranial management of pituitary tumours with suprasellar extension. J Neurol Neurosurg Psychiatry 42:123–133PubMedCrossRef
26.
Zurück zum Zitat Volcker HE, Gramberg-Danielsen B (1994) Damage to visual capacity. Recommendations of the German Ophthalmologic Society and the Workmen's Compensation Group 1994. Ophthalmologe 91:403–407PubMed Volcker HE, Gramberg-Danielsen B (1994) Damage to visual capacity. Recommendations of the German Ophthalmologic Society and the Workmen's Compensation Group 1994. Ophthalmologe 91:403–407PubMed
Metadaten
Titel
Functional impairments caused by chiasma syndromes prior to and following transsphenoidal pituitary adenoma surgery
verfasst von
Rudolf A. Kristof
Daniel Kirchhofer
Daniel Handzel
Georg Neuloh
Johannes Schramm
Christian-Andreas Mueller
Nicole Eter
Publikationsdatum
01.08.2010
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 8/2010
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-010-0654-1

Weitere Artikel der Ausgabe 8/2010

Acta Neurochirurgica 8/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.